Quantitative, not qualitative, differences in CD8+ T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice

Theiler's murine encephalomyelitis virus (TMEV) infection of the CNS induces an immune‐mediated demyelinating disease in susceptible mouse strains and serves as a relevant infection model for human multiple sclerosis. However, it is not yet clear what immunological parameters determine the susc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of immunology 2004-10, Vol.34 (10), p.2730-2739
Hauptverfasser: Lyman, Michael A., Myoung, Jinjong, Mohindru, Mani, Kim, Byung S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Theiler's murine encephalomyelitis virus (TMEV) infection of the CNS induces an immune‐mediated demyelinating disease in susceptible mouse strains and serves as a relevant infection model for human multiple sclerosis. However, it is not yet clear what immunological parameters determine the susceptibility of SJL/J mice compared to resistant mice. We have here compared the TMEV‐specific CD8+ T cell responses in highly susceptible SJL/J mice with those of highly resistant C57BL/6 mice. Our results clearly indicate that the levels of initial responses of infiltrating CD8+ T cells to viral capsid proteins are higher in resistant C57BL/6 mice compared to susceptible SJL/J mice. However, the level of virus‐specific CD8+ T cells was much more rapidly reduced in resistant C57BL/6, resulting in a higher CD8+ T cell level in SJL/J mice later in viral infection. The activation states, cytokine production, as well as the cytolytic function of the CD8+ T cells were similar to each other in these mice. These results suggest that an initial induction of a vigorous CD8+ T cell response to TMEV is critically important for the resistance to virally induced demyelinating disease.
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.200324811